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1. Introduction  
1.1 Background  
Psoriasis is an immune-mediated inflammatory disease of the skin affecting 2-3% of 
the Caucasian and 0.123% of the Chinese population (Raychaudhuri and Farber, 
2001;Yip, 1984). It is characterized by sharply demarcated erythematous plaques with 
silvery scales which appear typically on the knees, elbows, sacral region and scalp, 
but the entire skin may be involved. The pathogenesis of psoriasis is still not fully 
understood. A genetic predisposition and immunologic mechanisms seem to be 
mainly responsible for the development of skin lesions (Lowes et al., 2007). Psoriasis 
negatively affects patients' health-related quality of life (HRQoL) and results in a 
significant socioeconomic burden. 
Treatment of psoriasis is related to the extent of lesions and recent guidelines on 
evidence-medicine based criteria provide helpful background information on the 
choice of different drugs or regimens (Nast et al., 2007). Whereas in mild psoriasis 
according to a recent definition topical therapy is recommended systemic therapy is 
indicated for moderate to severe psoriasis (Mrowietz, 2011). There is the choice 
between conventional therapies such as methotrexate, ciclosporin and fumaric acid 
esters as first-line and biologic agents as second-line systemic treatment. 
 
Recent data on the pathogenesis of psoriasis focus on the involvement of specifically 
activated T cells on the background of a genetic susceptibility with HLA-Cw6 being the 
most important susceptibility gene. It is well known that dysregulated or uncontrolled 
effector T cell responses can lead to autoimmune diseases. CD4+ T cells expand and 
differentiate into different effector cells termed Th1, Th2, Th17 and Tregs 
characterized by the production of a certain subset of cytokines (Bettelli et al., 
2007;Mucida et al., 2007). The induction and progression of many autoimmune 
diseases is thought to be mediated by Th1 cells (Chang et al., 1997;Raychaudhuri 
and Farber, 2001) ,GHQWL¿FDWLRQRIWKH7KIDPLO\RIHffector T cells represented a 
major recent breakthrough (Kolls and Linden, 2004;Yao et al., 1995). Besides IL-17A, 
Th17 cells also release IL-17F, IL-21 and IL-22 (Korn et al., 2007;Liang et al., 
2006;Nurieva et al., 2007). It is currently believed that Th17 cells play a central role in 
host defense against certain pathogens and an exaggerated Th17 response might 
OHDG WR DXWRLPPXQH GLVHDVHV DQG VHYHUH LQÀDPPDWRU\ UHVSRQVHV (Cooper, 
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2007;Kolls and Linden, 2004). Th17 differentiation is regulated by various cytokines. 
Th17 differentiation can be induced by TGF-ȕ DQG ,/-6 in mice, and is further 
enhanced by IL-ȕDQG,/-21 in humans (Bettelli, Korn, and Kuchroo, 2007;Stockinger 
et al., 2007). The development of Th17 cells is negatively regulated by IFN-Ȗ DQG
IL-27, the signals of which are dependent on STAT1, and IL-2, dependent on STAT5, 
respectively (Harrington et al., 2005;Laurence et al., 2007;Stumhofer et al., 2006). In 
addition to cytokines, other mediators may impact Th17 cells differentiation. It has 
been shown that prostaglandin E2 (PGE2) favors human Th17 expansion (Boniface et 
al., 2009;Chizzolini et al., 2008;Napolitani et al., 2009). More recently, two groups 
have reported that the activated aryl hydrocarbon receptor (AhR) regulates regulatory 
T cells (Treg) and Th17 cell development and promotes Th17 polarization (Quintana 
et al., 2008;Veldhoen et al., 2008). 
AhR, also known as dioxin receptor, is a ubiquitous ligand-activated basic 
helix-loop-helix-PAS (bHLH-PAS)-44-containing transcription factor present in the 
cytoplasm. AhR binds to and is activated by a range of structurally divergent 
chemicals including natural dietary, endogenous ligands, and synthetic environmental 
agents among which dioxin (2,3,7,8-tetra-chlorodibenzo-p-dioxin (TCDD)) is the most 
extensively studied pure agonist (Beischlag et al., 2008;Bradshaw and Bell, 
2009;Nebert and Karp, 2008). Upon binding with a ligand, AhR undergoes a 
conformation change, translocates to the nucleus, and dimerizes with AhR nuclear 
translocator (Arnt). It regulates the expression of a variety of genes, including the 
xenobiotic metabolizing enzyme cytochrome P450 1A1 (CYP1A1) and cytochrome 
P450 1B1 (CYP1B1) (Denison and Nagy, 2003). Interestingly, it has been recently 
reported that AhR is a ligand-dependent E3 ubiquitin ligase (Ohtake et al., 2007), 
implying that AhR has dual functions in controlling intracellular protein levels, serving 
both as a transcriptional factor to promote the induction of target proteins and as a 
ligand-dependent E3 ubiquitin ligase to regulate selective protein degradation. 
There is considerable evidence to suggest that AhR signaling plays a role in the 
function of the immune system. A substantial amount of literature (Okey, 2007) 
described interactions of AhR with other key regulatory proteins including NF-ț%(Tian 
et al., 2002), which has a role in immune-mediated inflammation such as psoriasis. 
The nuclear AhR complex binds to the core nucleotide sequence xenobiotic 
responsive element (XRE), which occurs frequently in the mammalian genome and is 
also represented in IL-17A, IL-17F, IL-22 and ROR-ȖW,WKDVEHHQGHPRQVWUDWHGWKDW
agonists of the AhR play an integral role in T cell function, promoting a Th2/Th1 switch 
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resulting in a Th1 bias (Negishi et al., 2005). In the CD4+ T-cell lineage of mice AhR 
expression is restricted to the Th17 cell subset and its ligation results in the production 
of the Th17 cytokine IL-22. AhR-deficient mice showed decreased IL-17 development 
and absence of IL-22 production (Veldhoen et al., 2008). Th17 differentiation of mice 
naive CD4+ T cells was markedly inhibited in the presence of the AhR antagonist 
CH-223191. Additionally, it was shown that AhR was only induced under 
Th17-cell-inducing conditions. Collectively, Th17 differentiation represents an 
alternative biological system in which the effects of potential AhR agonists or 
antagonists can be directly tested. 
A number of compounds are described as AhR antagonists, including the flavone 
GHULYDWLYHV Į-QDSWKRIODYRQH Į-NF) (Wilhelmsson et al., 1994), 
5´-methoxy-6´-aminoflavone (PD98059) (Reiners, Jr. et al., 1998) and 
3´-methoxy-4´-nitroflavone (MNF) (Lu et al., 1995), 
6-methoxy-1,3,8-trichlorodibenzofuran (6-MCDF) (Astroff et al., 1988;Harris et al., 
1989), 1-amino-3, 7, 8-trichlorodibenzo-p-dioxin (Luster et al., 1986), omeprazole 
sulphide (Gerbal-Chaloin et al., 2006) and 6, 2´, 4´-trimethoxyflavone (TMF) (Murray 
et al., 2010). Interestingly, the plant kingdom is rich in AhR ligands predominantly in 
the form of polyphenolic flavonoid compounds. Many of these compounds exhibit 
anti-oxidant, anti-proliferative and anti-inflammatory activities.  
Extracts of the herb Tripterygium wilfordii Hook F. (TwHF), DOVRNQRZQDV³/HL*RQJ
7HQJ´DUHXVHGDVRQHRIWKHPRVWFRPPRQV\VWHPLFWUHDWPHQWVIRUGLVHDVHVVXFKDV
psoriasis in China mainly due to its favourable cost-benefit ratio. TwHF has been used 
for centuries in traditional Chinese medicine to treat rheumatoid arthritis. Originally, an 
extract obtained by boiling TwHF in water (decoction) was used for systemic 
treatment. Since a number of adverse effects were observed during therapy the 
extraction method was changed (Tao and Lipsky, 2000). With the aim to reduce 
toxicity an ethyl acetate extract and a chloroform±methanol extract (T2) were 
developed in the 1970s (Gutian Hospital and Beisha Hospital, 1972). Both of these 
preparations are commercially available in China and have been used extensively 
meanwhile.  
The extracts of TwHF contain more than 70 ingredients including diterpenoids, 
triterpenoids, sesquiterpenoids, ȕ-sitosterol, dulcitol, and glycosides (Chen, 2001). 
Triptolide (C20H24O6, chemical structure see Figure 1) turned out to be the active 
substance of TwHF extracts, which has been shown to possess potent 
anti-inflammatory and immunosuppressive properties in vitro as well as in different 
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animal models in numerous preclinical studies (Asano et al., 1998;Chang, Chang, 
Kuo, and Chang, 1997;Chang et al., 1993;Ho et al., 1999;Tao et al., 1998). Beside its 
use for the treatment of psoriasis, it has been shown that triptolide inhibits 
experimental autoimmune uveoretinitis and prolongs allograft survival (Kupchan et al., 
1972;Wu et al., 2003a). Moreover, it has been demonstrated that a succinyl derivative 
of triptolide, PG490-88, can prevent graft-versus-host disease (Chen et al., 2002). In 
addition to the anti-inflammatory and immunosuppressive activities, triptolide also 
exhibits potent anti-tumor and anti-leukemic activities (Jiang et al., 2001;Liu et al., 
2004;Wang et al., 2006). 
 
a  
   b  
c  
 
Figure 1. Chemical structure of TCDD (a), FICZ (b) and triptolide (c). 
 
The immunosuppressive action of triptolide has been generally attributed to 
suppression of T-lymphocyte activation. Triptolide induces apoptosis in lymphocytes 
and decreases the expression of IL-2 and IFN-Ȗ LQ 7 FHOOV E\ LQKLELWLQJ QXFOHDU
factor-kB (NF-kB) translocation (Chan et al., 1999;Qiu and Kao, 2003). 
In mice triptolide acts on the tumour necrosis factor D (TNFD)/tumour necrosis factor 
receptor 2 pathway of lymphocytes in the colon inhibiting the activation of NF-ț%DV
well as the expression of IFN-Ȗ(Wei et al., 2008). Furthermore, triptolide inhibits the 
production of lL-3, 4, 5, 6, and 8 by lymphocytes (Qiu and Kao, 2003). Recently, it was 
found that triptolide inhibited the differentiation of murine CD4+ T cells into Th17 cells 
in a dose dependent manner (Wang et al., 2008a). Triptolide decreased the 
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transcription level of IL-17 mRNA and IL-6-induced phosphorylation of STAT3, a key 
signaling molecule involved in the development of Th17 cells.  
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1.2 Purpose of the study  
From the molecular structure of triptolide (Figure 1) the hypothesis was generated that 
the compound could bind to AhR and serve as either agonist or antagonist. For this 
purpose it was investigated whether triptolide could induce cell death and affect FICZ 
induced CYP1A1 and CYP1B1 transcription on human keratinocytes. It was further 
explored if the exposure to triptolide could affect differentiation of naïve human T cells 
to Th17 cells and FICZ induced IFN-Ȗ ,/-17, IL-22, CYP1A1 and CYP1B1 
transcription on naïve human T cells.
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2 Materials and Methods  
2.1 Cell culture   
2.1.1 Cell lines  
2.1.1.1 Normal human epidermal keratinocytes (NHEK) 
Primary NHEK were purchased from Promocell (Heidelberg, Germany). NHEK-c adult 
were derived from adult normal human tissue from different locations, e.g. face, 
breast, abdomen, and thighs. Primary NHEK were cryopreserved in 1ml serum-free 
freezing medium (Cryo-SFM, PromoCell) in liquid nitrogen, containing >500 000 
viable cells after thawing. 
 
2.1.1.2 Naïve T cells 
2.1.1.2.1 Human peripheral blood mononuclear cells (PBMCs) isolation 
Human peripheral blood was collected in micro-hematocrit capillary tubes (Sarstedt, 
Nümbrecht, Germany) with 1mM ethylene diaminetetraacetic acid (EDTA) and diluted 
with the same volume of DuOEHFFR¶VSKRVSKDWH-buffered saline (PBS, without Ca & 
Mg, PAA Laboratories, Pasching, Austria). The dilution was underlayered by density 
gradient centrifugation using Ficoll-Paque separation medium (PAA Laboratories), 
and centrifuged for 30 min at 400 ×g at 18°C. The interphase containing mononuclear 
cells was harvested and washed twice with cold (6-8°C) PBS. The pellet was 
resuspended in 5ml ACK Lysis Buffer, which was prepared with 0.15M NH4Cl, 10mM 
KHCO3 and 0.1mM EDTA (all from Merck, Darmstadt, Germany) in ddH2O and 
adjusted to PH 7.2-7.4. The cell suspension was incubated at room temperature for 5 
minutes with occasional shaking. The reaction was stopped by diluting the Lysis 
Buffer with 30ml PBS and the cells were spinned at 400 ×g at 4°C. The number of 
cells was evaluated by staining with 0.4% trypan blue (Sigma-Aldrich, Steinheim, 
Germamy) and counting using a Bürker chamber. 
 
2.1.1.2.2 Naïve T cells separation 
2.1.1.2.2.1 Principle of the MACS® (Miltenyi Biotec) Separation 
Using the Naïve CD4+ T Cell Isolation Kit II (Miltenyi Biotech, Bergisch Gladbach, 
Germany), human untouched naïve CD4+ CD45RA+ T cells are isolated by depletion 
of non-T helper cells and memory CD4+ T cells. Non-T helper cells and memory CD4+ 
T cells are indirectly magnetically labeled with a cocktail of biotin-conjugated 
monoclonal antibodies, as primary labeling reagent, and Anti-Biotin MicroBeads, as 
secondary labeling reagent. The magnetically labeled non-T helper cells and memory 
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CD4+ T cells are depleted by retaining them on a MACS® Column in the magnetic field 
of a MACS Separator (both from Miltenyi Biotech), while the unlabeled naive CD4+ T 
cells pass through the column. 
 
2.1.1.2.2.2 Procedure of the MACS® Separation 
MACS buffer was prepared containing PBS, 0.5% bovine serum albumin (BSA, 
Sigma-$OGULFKDQGP0('7$ILOWHUHGWKURXJKȝPSRUHPHPEUDQH6DUVWHGW
and stored at 4°C. The cells were spinned at 300 ×g at 4°C and the pellet was 
resuspended in 40 µl of MACS buffer per 107 total cells. 10 µl of Naive CD4+ T Cell 
Biotin-Antibody Cocktail II per 107 total cells was added and well mixed. The cells 
were incubated for 10 minutes at 4°C and washed by adding 2 ml of buffer per 107 
cells and centrifuging at 300×g for 10 minutes. The supernatant was aspirated 
completely and the cell pellet was resuspended in 80 µl of buffer per 107 total cells. 20 
µl of Anti-Biotin MicroBeads per 107 total cells was added and well mixed. Thereafter 
the cells were incubated for 15 minutes at 4°C, washed repeatedly and resuspended 
in 500 µl of buffer. 
LS column was placed in the magnetic field of MACS Separator, and rinsed with 3ml 
buffer. The cell suspension was applied onto the column and flow-through containing 
unlabeled cells was collected in collection tube. The column was washed three times 
with the 3ml buffer and the total effluent was collected and combined with the effluent 
before, which comprised the enriched naive CD4+CD45RA+ T cell fraction. The cells 
were spinned at 400 ×g at 4°C. The number of cells was evaluated by staining with 
0.4% trypan blue and counting using a Bürker chamber. 
 
2.1.2 Cell culture conditions  
NHEK of passage 2 were re-cultured in serum-free keratinocyte growth medium 2 
(PromoCell) supplemented freshly with SupplementMix (PromoCell) at 37°C in a 5% 
CO2 atmosphere. NHEK was passaged by dissociation in trypsin/EDTA solution 
(0.04% trypsin/0.03% EDTA, PromoCell) for NHEK and trypsin neutralizing solution 
(0.05% trypsin inhibitor with 0.1% BSA, PromoCell). NHEK of passage 4 were used 
for the experiments.  
Naïve T cells were resuspended in RPMI (Gibco BRL, Karlsruhe, Germany) 
supplemented with 10% fetal calf serum (FCS , PAA Laboratories), HEPES (10 mM, 
Sigma-Aldrich), penicillin (100 U/ml), streptomycin (100 µg/ml, Biochrom AG, Berlin) 
and L-glutamine (2 mM, Biochrom AG, Berlin) in 24-well flat bottom plates (Sarstedt), 
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and stimulated with plate-bound anti-CD3 mAb (clone OKT3, 2.5 ȝJPl) and 
anti-CD28 mAb (clone 28.2, 1 µg/ml, BioLegend, San Diego, USA ). For human Th17 
differentiation, cells were supplemented with 10 ng/ml recombinant IL-ȕDQd 
20 ng/ml recombinant IL-6, 10 ng/ml IL-23 (all from R&D Systems, Wiesbaden, 
Germany), 1 ng/ml recombinant human transforming growth factor-beta (TGF-ȕ&+2
cell-derived, PromoCell), as previously reported. 
 
2.2 Neutral red assay  
2.2.1 Principles of neutral red assay  
The neutral red assay was developed for the assessment of the effect of toxic agents 
on cells in culture. The assay is based on the incorporation of the supravital dye 
neutral red (NR) into the lysosomes of viable cells after their incubation with toxic 
chemicals. This weakly cationic dye penetrates cell membranes by nonionic diffusion 
and binds intracellularly to sites of the lysosomal matrix (Lüllmann-Rauch, 1979). 
Xenobiotics that injure the plasma or lysosomal membrane decrease the uptake and 
subsequent retention of the dye. Dead or damaged cells cannot retain the dye after 
the washing and fixation procedures. After NR has been extracted from the 
lysosomes, it can be quantitated spectrophotometrically and the amount compared 
with the amount of dye extracted from control cell cultures. Quantification of the 
extracted dye has been shown to be linear with cell numbers (Borenfreund and 
Puerner, 1985a;Borenfreund and Puerner, 1985b). 
 
2.2.2 Procedures of neutral red assay  
Individual wells of a 96-well tissue culture microtiter plate were seeded with 0.2 ml of 
normal NHEK culture medium containing 2×104 NHEK cells, to achieve a 70 to 80% 
confluence after attachment and one day incubation. After 24h of incubation, the 
media were removed and replaced with 0.2 ml control medium or with 0.2ml medium 
with various concentrations of triptolide (TP, Sigma-Aldrich), which ranged from 
0.05µM, 0.1µM, 0.25µM to 0.5µM with a concentration of the primary solvent DMSO 
(Sigma-Aldrich) of 0.2%. Naïve T cells were seeded at a density of 2×105 /ml per well 
in the 96-well plates, treated with different concentration TP (0.3ȝ0, 0.1ȝ0, 0.06ȝ0, 
ȝ0 0.01ȝ0, ȝ0 ȝ0 UHVSHFWLYHO\ DQG LQFXEDWHG LQ D KXPLGLILHG
atmosphere with 5% CO2 at 37°C, in supplemented RPMI medium for 24 hours. Cells 
cultured in only medium served as control. 
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After 24h of exposure to TP the media were removed and replaced with 0.1ml/well 
medium containing 100µg of NR (Sigma-Aldrich) per ml (except for negative control). 
The NR-containing media were pre-incubated overnight at room temperature and 
filtered (0.2µm) prior to use to remove fine precipitates of dye crystals. The assay 
plate was then returned to the incubator for another 3 h to allow for uptake of the 
supravital dye into the lysosomes of viable cells. Thereafter, the media were removed 
and the cells were rapidly washed with 0.2 ml/well 1% formaldehyde-1% CaCl2 (all 
from Fluka, Buchs, Switzerland) followed by 0.2 ml/well of a solution of 1% acetic acid 
(Merck)-50% ethanol (J.T. Baker, Deventer, Netherlands) to extract the dye from the 
cells. After 10 min at room temperature and a brief but rapid agitation on a microtiter 
plate shaker, the plates were transferred to a microplate reader (SunriseTM Remote, 
TECAN, Austria) equipped with a 540-nm filter to measure the absorbance of the 
extracted dye at 540-nm versus 405-nm. The EC25 was calculated as the 
concentration of the agent (TP) at which 25% of the cells were positive for NR. 
 
2.3 MTT assay   
2.3.1 Principles of MTT assay 
Yellow MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, a tetrazole) 
is reduced to purple formazan in the mitochondria of living cells. The absorbance of 
this colored solution can be quantified by measuring at a certain wavelength (usually 
between 500 and 600 nm) by a spectrophotometer. The absorption max is dependent 
on the solvent employed. This reduction takes place only when mitochondrial 
reducing enzymes are active and therefore conversion can be directly related to the 
number of viable (living) cells. When the amount of purple formazan produced by cells 
treated with an agent is compared with the amount of formazan produced by 
untreated control cells, the effectiveness of the agent in causing death of cells can be 
deduced, through the production of a dose-response curve. Solutions of MTT 
solubilized in tissue culture media or balanced salt solutions, without phenol red, are 
yellowish in color. Mitochondrial dehydrogenases of viable cells cleave the tetrazolium 
ring, yielding purple MTT formazan crystals which are insoluble in aqueous solutions. 
The crystals can be dissolved in acidified isopropanol. The resulting purple solution is 
spectrophotometrically measured. An increase in cell number results in an increase in 
the amount of MTT formazan formed and an increase in absorbance. The MTT 
method of cell determination is useful in the measurement of cell growth in response 
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to mitogens, antigenic stimuli, growth factors and other cell growth promoting 
reagents, cytotoxicity studies, and in the derivation of cell growth curves (Michael et 
al., 1988;SLATER et al., 1963;van de Loosdrecht et al., 1940). 
 
2.3.2 Procedures of MTT assay  
For the experiments MTT (Sigma-Aldrich) was freshly prepared as 5 mg/ml in PBS 
without phenol red and serum, filtered (0.2 µm) prior to use and kept for 5 min at 37°C. 
Individual wells of a 96-well tissue culture microtiter plate were seeded with 0.2 ml of 
normal NHEK culture medium containing 2×104 NHEK cells, to achieve a 70 to 80% 
confluence after attachment and one day incubation. After 24h of incubation, the 
medium was removed and replaced with 0.2ml control medium or with 0.2ml medium 
with various concentrations of TP, which ranged from 0.003µM, 
0.01µM,0.03µM,0.05µM,0.08µM, 0.1µM, to 0.16µM with a concentration of the 
primary solvent DMSO (Sigma-Aldrich) of 0.2%. Naïve T cells were seeded at a 
density of 2×105 /ml per well in the 96-well plates, treated with different concentration 
TP (0.3ȝ0, 0.1ȝ0, 0.06ȝ0, ȝ00.01ȝ0, ȝ0ȝ0UHVSHFWLYHO\DQG
incubated in a humidified atmosphere with 5% CO2 at 37°C, in supplemented RPMI 
medium for 24 hours. Cells cultured in only medium served as control. 
After 24h of exposure to TP, the media were removed by aspiration and replaced with 
0.1ml/well medium containing 20µl MTT solution. The assay plate was then returned 
to the incubator for another 4 h to allow for uptake of MTT into the mitochondria of 
viable cells. Thereafter, the media were removed and replaced by 0.15 ml/well of a 
solution of 0.1% Nondet P-40 (NP40) with 4 mM HCl in isopropanol to dissolve the 
resulting purple MTT formazan crystals. The plate was then incubated in 37°C with 
agitation on a microtiter plate shaker to enhance dissolution. After 15 min, the plate 
was transferred to a microplate reader (SunriseTM Remote) equipped with a 570 nm 
filter to measure the absorbance of the extracted dye at 570 nm versus 690 nm. 
 
2.4 Quantitative Real-time Reverse transcriptase (RT)-PCR assays  
2.4.1 Treatment of cells with FICZ and TP 
2×105 NHEK were seeded to 24-well plates and cultured in normal NHEK medium to 
achieve about 80% ~90% confluence after attachment and 24-hour incubation. After 
washing with warm PBS once, cells were treaWHGZLWKȝ0),&=ȝ073RU
0.0ȝ0),&=ZLWKGLIIHUHQWFRQFHQWUDWLRQ73ȝ0ȝ0ȝ0
respectively in 1ml supplemented RPMI medium and incubated in a humidified 
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atmosphere with 5% CO2 at 37°C for 24 hours. Cells cultured in only medium served 
as control.  
Naïve T cells were seeded at a density of 2×106 /ml per well in the 24-well plates, 
WUHDWHGZLWKȝ0),&=ȝ073RUȝ0),&=ZLWKGLIIHUHQWFRQFHQWUDWLRQ73
ȝ0ȝ0ȝ0UHVSHFWLYHO\DQGLQFXEDWHGLQDKXPLGLILHGDWPRVSKHUH
with 5% CO2 at 37°C, in supplemented RPMI medium for 24 hours. Cells cultured in 
only medium served as control. 
 
2.4.2 RNA isolation  
Total RNA from NHEK or naïve T cells were extracted using Trizol reagent, according 
WRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQ,QYLWURJHQ.Drlsruhe, Germany). At the end of 
incubation, medium was removed. Cells were lysed by adding 0.5 ml per well of Trizol 
reagent and homogenized for 5 minutes at room temperature to permit the complete 
dissociation of nucleoprotein complexes. Each sample was PL[HGZLWKȝl 
chloroform (Sigma-Aldrich) at room temperature for 10 minutes. After centrifugation at 
îJIRUPLQXWHVDW&WKHVXSHUQDWDQWVZHUHPL[HGZLWKȝl 70% 
isopropanol (J.T.Baker) and kept at -20°C overnight. RNA pellets were collected by 
centrifugation at 8800×g for 10 minutes at 4°C. After washing with 0.5 ml 75% ethanol 
-7%DNHUSHOOHWVZHUHGLVVROYHGLQȝOZDWHU$OLTXRWVRI51$ZHUHVWRUHGDW
-80°C until further use.  
 
2.4.3 Formaldehyde Denaturing Agarose Gel Electrophoresis of RNA 
2.4.3.1 Principle of Formaldehyde Denaturing Agarose Gel Electrophoresis 
Denaturing agarose gel electrophoresis is used to control the size and integrity of 
RNA preparations. RNA has the tendency to form both secondary and tertiary 
structures that can impede its separation by electrophoresis. As such, identical 
species of RNA exhibiting varying degrees of intra molecular base pairing migrate at 
different rates and result in the smearing of distinct RNA molecules. Consequently, 
the electrophoresis of RNA needs to be performed under denaturing conditions. Heat 
denaturing the RNA sample prior to electrophoresis is insufficient, as secondary 
structures will simply reform unless a denaturing system is used. Successful 
electrophoresis of RNA is therefore accomplished in two steps: RNA is heat 
denatured prior to electrophoresis; during electrophoresis conditions have been 
established maintaining the RNA in a denatured state.  
In this assay, both formaldehyde and formamide are added to the sample before 
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electrophoresis to aid the denaturation of the RNA sample (Sambrook, 1989). 
 
2.4.3.2 Procedure of Formaldehyde Denaturing Agarose Gel Electrophoresis 
2.4.3.2.1 Preparation of buffer and gel 
10×MOPS buffer was prepared with 200 mM 3-[N-morpholino]propanesulfonic acid 
(MOPS, free acid, Sigma-Aldrich), 50 mM sodium acetate and 10 mM EDTA in ddH2O, 
and adjusted to pH 7.0 with NaOH.  
A Formaldehyde Agarose gel (1.2 % agarose) of size 10×14×0.7 cm was prepared 
using a mixture of 1.2 g agarose, 10 ml 10x MOPS buffer and RNase-free water to a 
final volume of 100 ml. The mixture was heated briefly to melt agarose and cooled to 
65°C in a water bath. 1.8 ml of 37% (12.3 M) formaldehyde (Fluka) and 10 µl SYBR® 
Green II RNA gel stain (10,000×concentrate in DMSO, Invitrogen) was added, mixed 
thoroughly and poured onto gel support with a comb that will form wells large enough 
to accommodate at least 25 µl.  
Formaldehyde Agarose gel running buffer was prepared with 20 ml 10x MOPS buffer, 
4 ml 37% (12.3 M) formaldehyde and 176 ml RNase-free water. 
The gel was assembled in the tank after 30 min, and covered by a few millimeters with 
1× Formaldehyde Agarose gel running buffer. The comb was then removed, and the 
gel was equilibrated in 1x Formaldehyde Agarose gel running buffer for at least 30 
min. 
 
2.4.3.2.2 Preparation of RNA samples 
5x loading buffer was prepared with 16 µl saturated aqueous bromophenol blue 
solution, 80 µl 500 mM EDTA, 720 µl 37% (12.3 M) formaldehyde, 2 ml 100% glycerol 
(Sigma-Aldrich), 3084 µl formamide, 4 ml 10 x MOPS buffer and RNase-free water to 
a final volume of 10 ml. 16µl of RNA sample containing 1µg RNA was mixed with 4µl 
of 5x loading buffer and incubated for 10 min at 65°C. 
 
2.4.3.2.3 Electrophoresis 
The denatured RNA was chilled on ice and loaded onto the equilibrated formaldehyde 
agarose gel. To avoid overheating and a smile effect on the migration of RNA and 
staining dye the gel was run at 5±7 V/cm in 1x formaldehyde agarose gel running 
buffer until the SYBR Green II dye has moved approximately half to three quarters of 
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the way along the gel. RNA was visualized using a 300-nm short-wave ultraviolet 
transilluminator. Pictures of gels were taken at f 4.5 for 1/2-1s. 
 
2.4.4 Reverse transcription 
51$FRQFHQWUDWLRQȝJȝOZDVGHWHUPLQHGE\PHDVXULQJWKHRSWLFDOGHQVLW\DW
nm with RNA/DNA calculator software Gene Quant. Equal amounts of total RNA from 
each sample were reverse-transcribed into cDNA with standard reagents according to 
the recommenGDWLRQVRIWKHPDQXIDFWXUHU,QYLWURJHQȝJ51$ZDVLQFXEDWHGZLWK
ȝJROLJRG7SULPHU)HUPHQWDVMainz, Germany) for 10 minutes at 70°C. 
$IWHULQFXEDWLRQ51$ZDVWUDQVIHUUHGLQWRDUHDFWLRQPL[WXUHFRQWDLQLQJȝl 
5×first-strand buffer (250 mM Tris-HCl, pH 8.3 at room temperature; 375 mM KCl; 15 
P00J&Oȝ'77P0ȝOG173VP0DQGȝl Superscript IITM 
reverse transcriptase (all from Invitrogen) and incubated at 42°C for 60 minutes. 
Transcription was stopped at 90°C for 5 minutes. Thereafter the products were stored 
at -80°C until further use.  
 
2.4.5 Real time quantitative PCR and data analysis 
Real time quantitative PCR and data analysis was carried out using pre-developed 
QuantiTect primer assays for human IFN-Ȗ +VBP1), IL-17 
(Hs00174383_m1), IL-22 (Hs001574154_m1), CYP1A1 (Hs00153120_m1), CYP1B1 
(Hs009164383_m1) and GapdH (Hs99999905_m1, all from Applied Biosystem, New 
Jersey, USA) with FAM detection on an ABI Prism 7300 Sequence Detection System 
(Roche Diagnostics, Manheim, Germany).  
c'1$FRUUHVSRQGLQJWRQJ51$VHUYHGDVDWHPSODWHLQDȝOUHDFWLRQV\VWHP
FRQWDLQLQJȝ0RIHDFKSULPHUDQG×TaqMan Universal PCR Master Mix (Applied 
Biosystem). Samples were loaded into MicroAmp® Optical 96-Well Reaction Plate 
(Applied Biosystem) and sealed with adhesive covers (Applied Biosystem). The plates 
were centrifuged briefly to remove air bubbles and collect the liquid at the bottom, and 
then incubated in the thermal cycler block for an initial activation of AmpliTaq Gold 
enzyme at 95°C for 30 seconds followed by 45 cycles, each cycle consisting of 
denaturing by 95°C for 15 seconds and extending by 60°C for 1 min. 
In all cases, melting point analysis revealed amplification of a single product. Data 
acquisition and analysis were achieved using Applied Biosystem software (Applied 
Biosystem). Relative abundance of each target transcript in unstimulated or 
stimulated samples was normalized to GapdH using the formula 2-¨&7ZKHUH¨&W 
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CtTARGET - CtGapdH. Fold change values correspond to the difference of target transcript 
relative abundance in stimulated compared to unstimulated samples and were 
calculated using the formula 2-¨¨&7ZKHUH¨¨&W ¨&WSTIMULATED ± ¨&WUNSTIMULATED.    
 
2.5 Fluorescent Activated Cell Sorting (FACS) analysis 
2.5.1 Principle of flow cytometric analysis 
Flow cytometry is the measurement of various physicochemical characteristics of 
suspended cells. The procedure is typically performed in combination with the use of 
fluorescent probes that stain cellular components or functions (Shapiro, 2005). Using 
a microfluidic system that directs a high-speed single-file stream of cells to a focused 
laser beam in a glass capillary tube, flow cytometers capture light scattering at 
different angles and fluorescence emissions at several wavelengths for each 
individual cell. Detected light signals are collected by a series of optical systems and 
processed by data-analysis electronics to measure morphological, biochemical and 
functional properties of cells such as size, shape, DNA content, cell surface markers, 
cell cycle distribution and viability. Such combined implementation of microfluidics, 
optics and electronics in modern flow cytometers provides a robust platform to 
quantify multiple characteristics of sample populations (e.g. cells, viruses, bacteria, 
yeast, aerosol particles, microbeads) simultaneously at high rates (up to 
approximately 25000 cells/s). For the past three decades, advances in precision 
technologies, dye synthesis and high-speed data-handling techniques have exerted 
synergistic effects on flow cytometry, bringing this powerful analytical tool into routine 
clinical and laboratory use in the field of cell/molecular biology (Boeck, 2001), disease 
diagnostics (Stein et al., 1992), immunology (Gabriel and Kindermann, 1995), 
genetics (Wedemeyer and Potter, 2001) and environmental monitoring (Dubelaar and 
Gerritzen, 2000). 
 
2.5.2 Procedure of FACS analysis 
2.5.2.1 Treatment of cells with FICZ and TP 
Naïve T cells were seeded at a density of 1×106 /ml per well in the 24-well plates with 
plate-bound anti-CD3 mAb (clone OKT3, 2.5 ȝJPODQGDQWL-CD28 mAb (clone 28.2, 
1 µg/ml) in supplemented RPMI medium. For human Th17 differentiation, cells were 
supplemented with 10 ng/mL recombinant IL-ȕDQG ng/ml recombinant IL-6, 
100 ng/ml IL-23, 1 ng/ml TGF-ȕDVSUHYLRXVO\UHSRUWHG 
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7KHFHOOVZHUHWUHDWHGIURPWKHEHJLQQLQJZLWKȝ0),&=ȝ0),&=SOXVGLIIHUHQW
concentration of TP or left with supplemented medium alone respectively and 
incubated in a humidified atmosphere with 5% CO2 at 37°C for 72 hours. TP was 
DGGHGWRWKHZHOOVDWILQDOFRQFHQWUDWLRQVRIȝ0ȝ0DQGȝ0SHUZHOO  
2.5.2.2 Cell stimulation  
After 72-hours incubation periods, the cells of every well were transferred into a 1.5 ml 
sterile centrifuge tube (Sarstedt) and washed twice with PBS. Cells were 
resuspended in 200µl RPMI medium and pipetted to 96-well U-bottom plate (Sarstedt). 
PdBU 50 nM, Ionomycin 500 ng/ml and Brefaldin A 10 µg/ml was added to each well. 
The plate was incubated with 5% CO2 at 37°C for three hours. 
2.5.2.3 Staining of the cells with antibodies  
2.5.2.3.1 Surface staining with antibody against CD45-PE 
FACS buffer was prepared with 2% heat inactivated FCS and 0.09% (w/v) sodium 
D]LGHLQ'XOEHFFR¶V3%6DGMXVWHGWRS+-ILOWHUHGWKURXJKȝPSRUH
membrane, and stored at 4°C. Cells after 3h incubation were washed once with FACS 
buffer by centrifugation at 400×g at 4°C for 5 minutes. Thereafter, cells were 
pre-incubated with 5ul mouse serum for 10 min at room temperature to block 
non-VSHFLILFELQGLQJ7KHQFHOOVZHUHUHVXVSHQGHGLQXO)$&6EXIIHUZLWKȝO
fluorochrome-conjugated monoclonal antibody CD45-PE or the corresponding 
PE-labeled immunoglobulin isotype control antibody as control and incubated for 20 
PLQDW&LQGDUN7KHUHDIWHUFHOOVZHUHZDVKHGWZLFHZLWKȝOZHOO)$&6EXIIHU
and supernatant was discarded. 
 
2.5.2.3.2 Intracellular staining with antibodies against IL-17, IL-22 and IFN-Ȗ 
&HOOVZHUHWKRURXJKO\UHVXVSHQGHGLQȝORI%'&\WRIL[&\WRSHUPVROXWLRQIRU
min at room temperature. Then all wells were washed two times in 1×BD 
3HUP:DVKVROXWLRQ7KHIL[HGSHUPHDELOL]HGFHOls were thoroughly resuspended in 
ȝORI%'3HUP:DVKVROXWLRQFRQWDLQLQJXO$QWL-IL17-Pc5.5 Conjugated 
Antibody (clone eBio64DEC17, ebioscience) , 5ul Anti-IL22-PE Conjugated Antibody 
(clone BG/IL22, BioLegend) and 5ul Anti- IFN-Ȗ-PE-Cy7 Conjugated Antibody (clone 
4S.B3, ebioscience) or corresponding IgG1-Pc5.5,IgG1-PE and IgG1-PECy7 -labeled 
isotype control antibodies as control. After 30 min incubation at 4°C in the dark, cells 
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were washed two times with FACS buffer to remove all unbound reagents and 
UHVXVSHQGHGLQȝO)$&6%XIIHr prior to flow cytometric analysis.  
 
2.5.2.4 Flow cytometric analysis  
Analysis was performed using an EPICS-XL flow cytometer together with system II 
software (Beckman-Coulter). Cells were gated according to forward and side scatter 
characteristics. For each sample, at least of 100 000 viable cells were analyzed and 
the results were expressed as the mean percentage of cells staining positive.  
 
2.6 Apo2.7 cytotoxicity test in naïve T cells  
2.6.1 Principles of Apo2.7 assay 
Apoptosis, or programmed cell death, plays a fundamental role in many normal 
biological processes as well as several disease states (Cohen et al., 1992;Ellis et al., 
1991;Nicholson, 1996;Thompson, 1995;Wyllie et al., 1980). Apoptosis can be induced 
by various stimuli that all produce the same end result: systematic and deliberate cell 
death. The 2.7A6A3 monoclonal antibody (mAb) reacts with the APO2.7 antigen (also 
called 7A6 antigen) that is a 38 kDa mitochondrial membrane protein which appears 
to be exposed on cells undergoing apoptosis (programmed cell death). It has been 
suggested that APO2.7 protein is involved in the molecular cascade of apoptosis and 
its expression represents an early event of apoptosis rather than a final product of 
dead cells (Zhang et al., 1996). Normal viable cells are negative or weakly positive for 
APO2.7. Research studies have shown that less than 2% of peripheral T cells from 
normal donors expressed the APO2.7 antigen. Some level of APO2.7 expression 
associated with an on-going apoptotic process has been demonstrated in activated T 
cells. By flow cytometric analysis, the APO2.7 antigen can be detected after apoptosis 
induction via CD95/Fas ligation, irradiation or drug treatment. The 2.7A6A3 mAb 
strongly reacts with cells induced to undergo apoptosis (Pepper et al., 1998;Zhang et 
al., 1996). In contrast, this mAb fails to stain or weakly stains untreated and 
digitonin-permeabilized human peripheral blood cells and hematopoietic cell lines 
(Jurkat, Molt-4, etc.). Apo2.7 also reacts specifically with apoptotic Jurkat cells 
induced by gamma-irradiation, Ara-C treatment, or CD95 (Fas) antibody ligation 
(Koester et al., 1997;Zhang et al., 1996). 
 
2.6.2 Procedures of Apo2.7 assay  
2.6.2.1 Treatment of cells with TP 
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For determination of Apo2.7-expression, naïve T cells were seeded at a density of 
1×106 /ml per well in the 24-well plates, respectively and incubated in a humidified 
atmosphere with 5% CO2 at 37°C, in supplemented RPMI medium for 24 hours.  
The cells were treated from the beginning with TP or left with supplemented RPMI 
medium alone. TP was added to the wells at final concentrations of 0.3ȝ0, 0.1ȝ0, 
ȝ0ȝ0DQGȝ0SHUZHOO&HOOVZLWKRXWDQ\DGGLWLRQRI73VHUYHGDVD
medium control. 
 
2.6.2.2 Cell stimulation 
After 24-hours incubation periods, the cells of every well was transferred into a 1.5 ml 
sterile centrifuge tube (Sarstedt) and washed twice with PBS. Cells were 
resuspended in 200µl RPMI medium and pipetted to 96-well U-bottom plate. 
Phorbol-12-13-dibutyrate (PdBU) 50 nM, Ionomycin 500 ng/ml and Brefaldin A 10 µg / 
ml was added to each well. The plate was incubated with 5% CO2 at 37°C for three 
hours. 
 
2.6.2.3 Staining of the cells with antibodies 
2.6.2.3.1 Surface staining with antibody against CD45-PE 
Cells after 3h incubation were washed once with FACS buffer by centrifugation at 400 
×g at 4°C for 5 minutes. Thereafter, cells were pre-incubated with 5ul mouse serum 
(eBioscience) for 10 min at room temperature to block non-specific binding. Then cells 
ZHUHVXVSHQGHGLQXO)$&6EXIIHUZLWKȝOIOXRURFKURPH-conjugated monoclonal 
antibody CD45-PE (Beckman coulter, Marseille, France) or the corresponding 
PE-labeled immunoglobulin isotype control antibody as control. The cell suspension 
was incubated for 20 min at 4°C in dark. Thereafter cells were washed twice with 
ȝOZHOO)$&6EXIIHUDQGVXSHUQDWDQWZDVUHPRYHG 
 
2.6.2.3.2 Intracellular staining with antibodies against Apo 2.7  
&HOOVZHUHWKRURXJKO\UHVXVSHQGHGLQȝORI%'&\WRIL[&\WRSHUP%'
bioscience, San Diego, CA, USA) solution for 20 min at room temperature. Then all 
wells were washed two times in 1×%'3HUP:DVKVROXWLRQ7KH
IL[HGSHUPHDELOL]HGFHOOVZHUHWKRURXJKO\UHVXVSHQGHGLQȝORI%'3HUP:DVK
solution, containing 5ul Anti-APO2.7-Pc5 Conjugated Antibody (clone 2.7A6A3, 
Beckman-Coulter, Krefeld) or corresponding PC5-labeled isotype control antibodies 
(DAKO, Glostrup, Denmark) as control. After 30 min incubation at 4°C in the dark, 
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cells were washed two times with FACS buffer to remove all unbound reagents and 
UHVXVSHQGHGLQȝO)$&6%XIIHUSULRUWRIORZF\WRPHWULFDQDO\VLV 
 
2.6.2.4 Flow cytometric analysis  
The apoptosis-inducing effect of TP on Naïve T cells was assessed by single colour 
flow cytometry. Analysis was performed using an EPICS-XL flow-cytometer together 
with system II software (Beckman-Coulter). Cells were gated according to forward and 
side scatter characteristics. For each sample, at least of 100 000 viable cells were 
analyzed and the results were expressed as the mean percentage of cells staining 
positive. Experiments were performed in duplicate.  
 
2.7 Enzyme-linked immunosorbent assay (ELISA) 
2.7.1 Principle of ELISA 
ELISA is a rapid immunochemical test that involves an enzyme (a protein that 
catalyzes a biochemical reaction). It also involves an antibody or antigen 
(immunologic molecules). ELISA tests are utilized to detect substances that have 
antigenic properties, primarily proteins (as opposed to small molecules and ions such 
as glucose and potassium). It is a highly sensitive and specific method in estimating 
ng/ml to pg/ml ordered materials in the solution, such as serum, urine, sperm and 
culture supernatant (Savige et al., 1998).  
There are variations of this test, but the most basic consists of an antibody attached to 
a solid surface. This antibody has affinity for (will latch on to) the substance of interest, 
for example, human chorionic gonadotropin (HCG), the commonly measured protein 
which indicates pregnancy. A mixture of purified HCG linked (coupled) to an enzyme 
and the test sample (blood, urine, etc) are added to the test system. If no HCG is 
present in the test sample, then only HCG with linked enzyme will bind. The more 
HCG which is present in the test sample, the less enzyme linked HCG will bind. The 
substance the enzyme acts on is then added, and the amount of product measured in 
some way, such as a change in color of the solution. 
 
2.7.2 Procedure of ELISA 
2.7.2.1 Treatment of cells with FICZ and TP 
Naïve T cells were seeded at a density of 1x106 /ml per well in the 24-well plates with 
plate-bound anti-CD3 mAb (clone OKT3, 2.5 ȝJPl) and anti-CD28 mAb (clone 37.51, 
1 µg/ml) in supplemented RPMI medium. For human Th17 differentiation, cells were 
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supplemented with 10 ng/ml recombinant IL-ȕDQG ng/ml recombinant IL-6, 
10 ng/ml IL-23, 1 ng/ml TGF-ȕDVSUHYLRXVO\UHSRUWHG 
7KHFHOOVZHUHWUHDWHGIURPWKHEHJLQQLQJZLWKȝ0),&=ȝ0),&=SOXVGLIIHUHQW
concentration of TP or left with supplemented medium alone respectively and 
incubated in a humidified atmosphere with 5% CO2 at 37°C for 72 hours. TP was 
DGGHGWRWKHZHOOVDWILQDOFRQFHQWUDWLRQVRIȝ0ȝ0DQGȝ0SHUZHOO  
 
2.7.2.2 Cell stimulation  
After 72-hours incubation period, the cells of each well were transferred into a 1.5 ml 
sterile centrifuge tube and washed twice with PBS. Cells were resuspended in 200µl 
RPMI medium and pipette to 96-well plate. PdBU 50 nM and ionomycin 500 ng/ml 
was added to each well. The plate was incubated at 37°C in a 5% CO2 atmosphere. 
After five hours, cells were spinned and the supernatants were stored in new 1.5ml 
sterile centrifuge tube in -80°C for ELISA. 
 
2.7.2.3 IL-17A, IL-22 and IFN-ȖGHWHFWLRQZLWK(/,6$   
The ELISA was carried out according to the PDQXIDFWXUHU¶VLQVWUXFWLRQRI+XPDQ
IL-17A ELISA Ready-SET-Go!TM Kit, Human IL-22ELISA Ready-SET-Go!TM Kit and 
Human IFN-Ȗ(/,6$5HDG\-SET-Go!TM Kit (all from eBioscience). The high affinity 
protein binding plates (Corning Costar 9018) were pre-coated with 100 µl/well of IL-17, 
IL-22 or IFN-ȖFDSWXUHDQWLERG\LQFRDWLQJ%XIIHUGLOXWHGUHVSHFWLYHO\VHDOHG
with mylar and incubated overnight at 4°C. Each plate was washed 5 times with 250 
µl/well wash buffer (0.05% Tween-20 in PBS) the next day. Thereafter the wells were 
blocked with 200 µl/well of 1×Assay Diluent and incubated at room temperature for 1 
hour. After five times washing, 100 µl/well of individual standard dilution (diluted with 
1×Assay Diluent to concentrations of 7.8125 pg/µl, 15.625 pg/µl, 31.25 pg/µl, 62.5 
pg/µl, 125 pg/µl, 250 pg/µl and 500 pg/µl) and sample dilutions (1:10 diluted with 
1×Assay Diluent) were added to the appropriate wells. The plates were sealed and 
incubated overnight at 4°C for maximal sensitivity. After a repetition of washing steps 
the next day, 100 µl/well of IL-17, IL-22 or IFN-ȖGHWHFWLRQDQWLERG\GLOXWHGLQ
1×Assay Diluent) was added to respective plates. Then the plates were sealed and 
incubated at room temperature for one hour. 100 µl/well of Avidin Horseradish 
Peroxidase (AV-HRP, 1:250 diluted in 1×Assay Diluent) was added after repeated 
washing steps. The plates were sealed and incubated at room temperature for 30 min. 
Then 100 µl/well of Tetramethylbenzidine (TMB) substrate solution was added to 
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each well after seven times aspirate and wash of the plates. The addition of 50 µl of 
stop solution (1M H3PO4) is completed into the wells. The plate was transferred to a 
microplate reader (SunriseTM Remote) within 30 minutes and the absorbance was 
measured with a 450 nm filter. A formula made according to the concentration and 
UHVSHFWLYHǻ2'PLQRIVWDQGDUGVZDVXVHGWRquantify samples measured.  
 
2.8 Statistical analysis  
The data obtained in our study were expressed as mean ± standard deviation. EC 
values and corresponding 95% confidence intervals were calculated by SPSS 
software (SPSS, Inc., USA). Statistical significance between groups of the samples 
was evaluated by t-test. A p-value below 0.05 was considered significant and 
indicated by one asterisk (*), and p-value below 0.01 was considered significant and 
indicated by two asterisk (**). 
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3. Results  
3.1 Neutral red assay  
TP-induced cytotoxicity in keratinocytes was determined by using the neutral red 
assay. NHEK were cultured with TP for 24h. The following concentrations of TP were 
used: 0.05µM, 0.1µM, 0.25µM and 0.5µM. After 24h incubation with TP a small 
proportion of the cultured cells were found dead as observed under the inverted 
microscope. The proportion of damaged cells differed according to the different 
TP-concentrations. The relative neutral red absorbance corresponding to different 
TP-concentrations is shown in Figure 2. Generally, absorbance of neutral red 
increased when the TP concentration decreased. The EC25 value of TP in NHEK 
could be calculated as 0.0547µM. Therefore, 0.05µM was used as the highest 
concentration of TP in the following experiments with NHEK. 
 
Figure 2 Relative absorbance of neutral red corresponding to different TP 
concentrations in NHEK. Mean of two independent experiments.  
 
To detect cytotoxicity effects of TP in naïve T cells, the following concentrations of TP 
were used: 0. 30µM, 0.10µM, 0.06µM, 0.03µM, 0.01µM, 0.003µM and 0.0003µM. 
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After 24h incubation with TP a small proportion of the cultured cells were found dead 
as observed under the inverted microscope. The proportion of damaged cells differed 
according to the different TP-concentrations. The relative neutral red absorbance 
corresponding to different TP-concentrations is shown in Figure 3.The EC25 value of 
TP in Naïve T cells could be calculated as 0.0282µM. Therefore, 0.03µM was used as 
the highest concentration of TP in the following experiments with Naïve T cells. 
 
 
Figure 3 Relative absorbance of neutral red corresponding to different TP 
concentrations in Naïve T cells. Mean ± SD of four independent experiments. 
**P<0.01;*P<0.05. 
 
3.2 MTT assay  
To detect effects of TP on the proliferation of keratinocytes, NHEK were incubated 
with different concentrations of TP (0. 16, 0.10, 0.08, 0.05, 0.03, 0.01, 0.003µM) or 
0.16µM FICZ. Cells were harvested for MTT analysis after 24h-incubation. The 
relative MTT absorbance corresponding to different TP concentrations is shown in 
Figure 4. Absorbance of MTT increased when the TP concentration decreased. TP at 
concentrations above 0.03µM showed a significant inhibitory effect on the proliferation 
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of keratinocytes (P<0.01). FICZ showed no inhibitory effect at the concentration of 
0.16µM. 
 
Figure 4: TP inhibited proliferation of keratinocytes in a dose-dependent fashion. 
Mean ± SD of three independent experiments. **P<0.01. 
 
To detect effects of TP on the proliferation of naïve T cells, the following 
concentrations of TP was used: 0. 30, 0.10, 0.06, 0.03, 0.01, 0.003, 0.0003µM. Cells 
were harvested for MTT analysis after 24h-incubation. The relative MTT absorbance 
corresponding to different TP concentrations is shown in Figure 5. Absorbance of 
MTT increased when the TP concentration decreased. TP at concentrations above 
0.003µM showed a significant inhibitory effect on the proliferation of keratinocytes 
(P<0.05). 
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Figure 5: TP inhibited proliferation of naïve T cells in a dose-dependent fashion. Mean 
± SD of four independent experiments. **P<0.01;*P<0.05. 
 
3.3 Quantitative Real-time RT-PCR assays 
3.3.1 Formaldehyde Denaturing Agarose Gel Electrophoresis of RNA 
To assess the quality of RNA after cell lysis, denaturing agarose gel electrophoresis 
was performed before quantitative real-time PCR. One µg of degraded total RNA from 
each sample was subjected to a 1.2% denaturing agarose gel and visualized on a UV 
transilluminator. Intact total RNA on a denaturing gel showed sharp 28S and 18S 
rRNA bands (eukaryotic samples). The 28S rRNA band was approximately twice as 
intense as the 18S rRNA band (Figure 6). This 2:1 ratio (28S:18S) was a good 
indicator for RNA integrity. These RNA-preparations were used for further quantitative 
real-time PCR. 
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Figure 6 Formaldehyde denaturing agarose gel electrophoresis of RNA. The 18S and 
28S ribosomal RNA bands are clearly visible in the intact RNA sample. 
 
3.3.2 Expression of mRNA for CYP1A1 and CYP1B1 in NHEK 
To examine the effect of TP on AhR-responsive transcriptor production at mRNA 
levels, quantitative real-time PCR was used to determine the level of CYP1A1 and 
CYP1B1 mRNA expression in human keratinocytes. NHEK (2×105) were incubated 
ZLWK),&=ȝ0DORQHRU),&=ȝ0DQGGLIIHUHQWFRQFHQWUDWLRns of TP 
(0.05µM, 0.025µM, 0.001µM). Total RNA was harvested after 24h-incubation and the 
expression of CYP1A1 and CYP1B1 was determined by quantitative real-time PCR 
analysis. Data represent relative mRNA levels of the indicated target gene normalized 
against Hprt. As shown in figure 7 FICZ-induced AhR-dependent CYP1A1 and 
CYP1B1 expression was significantly inhibited by TP at a concentration of 0.05µM in 
NHEK. 
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Figure 7 Inhibitory effect of TP on FICZ-induced production of CYP1A1 and CYP1B1 
by NHEK at the transcriptional level. Mean + SD of at least three independent 
experiments. **P<0.01.* P<0.05. 
 
3.3.3 Expression of mRNA of IFN-Ȗ,/-17, IL-22, CYP1A1 and CYP1B1 in naïve T 
cells 
Naïve T cells (2×106ZHUHLQFXEDWHGZLWK),&=ȝ0DORQHRU),&=ȝ0
together with TP (0.03µM, 0.003µM, 0.0003µM). Total RNA was harvested after 
24h-incubation and FICZ-induced AhR-dependent mRNA-expression of CYP1A1 and 
CYP1B1, IFN-Ȗ, IL-17 and IL-22 was determined by quantitative real-time PCR 
analysis. Data shown in figure 8 represent relative mRNA levels of the indicated target 
gene normalized against GAPDH. FICZ-induced expression of AhR-dependent 
CYP1A1, CYP1B1, IFN-Ȗ, IL-17 and IL-22 was significantly inhibited by TP at a 
concentration of 0.03µM in naïve T cells. 
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Figure 8 Inhibitory effect of TP on FICZ-induced mRNA-expression of CYP1A1, 
CYP1B1, IFN-Ȗ,/-17 and IL-22 in naïve T cells. Mean + SD of three independent 
experiments. **P<0.01.* P<0.05. 
3.4  FACS analysis 
To determine the effect of TP on the intracellular expression of cytokines by naïve T 
cells, 1×106 QDwYH7FHOOVZHUHLQFXEDWHGZLWK),&=ȝ0DORQHRUZLWK),&=
ȝ0DQG73000&HOOVZHUHUHVWLPXODWHGZLWK3'%8
ionomycin and brefaldin A after 72h-incubation. Cells were washed, incubated with 
fluorescence labeled antibodies and analyzed at the single cell level by FACS. The 
results showed that there are very few IL-17- and IL-22-producing T cells in control 
cultures stimulated with anti-CD3 and anti-CD28 mAb (Figure 9). Addition of IL-ȕ
IL-6, IL-23 and TGF-ȕSURPRWHGthe expression of IL-22 and IL-17 (Figure 10) in 
particular together with the addition of FICZ (Figure 11). In this experimental setting 
TP inhibited IL-17-, IL-22- and IFN-Ȗ-expression as shown in Figures 12, 13 and 14. In 
the SUHVHQFHRIȝ073RQO\Rne division of cells (IFN-ȖZDVREVHUYHG)LJXUH12) 
suggesting that TP could inhibit the division in IL-ȕ,/-6/IL-23/ TGF-ȕ 
antibody-stimulated naïve T cells. The inhibition of cytokines showed a significant 
dose-related effect as compared to the FICZ-induced cultures (Figure 15). The data 
was representative of three independent experiments with similar results. 
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Figure 9 Flow cytometric analysis of IFN-Ȗ,/-17 and IL-22 in T cells stimulated with 
anti-CD3 and anti-CD28 mAb. 
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Figure 10 Flow cytometric analysis of IFN-Ȗ,/-17 and IL-22 in T cells stimulated with 
10 ng/ml IL-ȕ ng/ml IL-6, 10 ng/ml IL-23, 1 ng/ml TGF-ȕWRJHWKHUZLWKanti-CD3 
and anti-CD28 mAb. 
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Figure 11 Flow cytometric analysis of IFN-Ȗ,/-17 and IL-22 in naïve T cells 
stimulated with 0.03ȝ0 FICZ and 10 ng/ml IL-ȕ ng/ml IL-6, 10 ng/ml IL-23, 
1 ng/ml TGF-ȕWRJHWKHUZLWKanti-CD3 and anti-CD28 mAb. 
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Figure 12 Flow cytometric analysis of IFN-Ȗ,/-17 and IL-22 in naïve T cells 
stimulated with 0.03ȝ0 FICZ plus 0.03ȝ0 TP and 10 ng/ml IL-ȕ ng/ml IL-6, 
10 ng/ml IL-23, 1 ng/ml TGF-ȕWRJHWKHUZLWKanti-CD3 and anti-CD28 mAb. 
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Figure 13 Flow cytometric analysis of IFN-Ȗ,/-17 and IL-22 in naïve T cells 
stimulated with 0.03ȝ0 FICZ plus 0.003ȝ0 TP and 10 ng/ml IL-ȕ ng/ml IL-6, 
10 ng/ml IL-23, 1 ng/ml TGF-ȕWRJHWKHUZLWKanti-CD3 and anti-CD28 mAb. 
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Figure 14 Flow cytometric analysis of IFN-Ȗ,/-17 and IL-22 in naïve T cells 
stimulated with 0.03ȝ0 FICZ plus 0.0003ȝ0 TP and 10 ng/ml IL-ȕ ng/ml IL-6, 
10 ng/ml IL-23, 1 ng/ml TGF-ȕWRJHWKHUZLWKanti-CD3 and anti-CD28 mAb.  
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Figure 15 Treatment with triptolide decreased IFN-Ȗ,/-17 and IL-22 levels and 
showed a dose-dependent repression of FICZ-induced cytokine expression. nsCTRL, 
naïve T cells treated with only anti-CD3 and anti-CD28; CTRL, naïve T cells treated 
with IL-ȕ,/-6 and IL-23 together with anti-CD3 and anti-CD28. **P<0.01. 
 
3.5 Apo2.7 cytotoxicity test in naïve T cells 
To explore if TP induced apoptosis naïve T cells were treated from the beginning with 
TP at final concentrations of 0.3ȝ0, 0.1ȝ0, ȝ0ȝ0DQGȝ0 The cells 
were restimulated with PDBU, ionomycin and brefaldin A after 24h-incubation. Cells 
were incubated with Apo2.7 antibodies and analyzed by flow cytometric analysis. TP 
LQFRQFHQWUDWLRQDERYHȝ0LQGXFHGDVLJQLILFDQWLQFUHDVHLQDSRSWRVLVLQQDïve T 
cells (Figure 16). 
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Toxicity test (Naive T cells + Triptolide 24hr)
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Figure 16 Induction of apoptosis in naïve T cells by triptolide. Expression of the 
early apoptosis marker Apo2.7 was analyzed by flow cytometry. 
 
3.6 ELISA 
To determine whether IFN-Ȗ,/-17 and IL-22 production was regulated simultaneously 
DWWKHSURWHLQOHYHOQDwYH7FHOOVZHUHLQFXEDWHGZLWK),&=ȝ0DORQH),&=
ȝ0WRJHWKHUZLWKTP ȝ0RU),&=ȝ0WRJHWKHUZLWKYDULRXV
concentrations of TP (0.03, WRȝ0$VVKRZQLQ)LJXUH7A, stimulation 
with FICZ resulted in a high level production of IFN-Ȗ,/-17 and IL-22 after 
72h-incubation. Treatment with TP decreased IFN-Ȗ,/-17 and IL-22 levels and 
showed a dose-dependent decrease of FICZ-induced cytokines production.  
In a second set of experiments the culture medium was removed after 72h-incubation 
and naïve T cells were restimulated with PDBU and ionomycin. The supernatants 
were harvested for ELISA after 5h-incubation. The data are shown in Figure 17B. 
Stimulation with FICZ resulted in significantly higher levels of IFN-Ȗ,/-17 and IL-22 
as compared to control cultures. When cells were incubated in the presence of 
various concentrations of TP the production of FICZ-induced IFN-Ȗ,/-17 and IL-22 
was significantly decreased in a dose-dependent manner (P<0.001 or P<0.05, 
FRPSDUHGWRFXOWXUHVZLWK),&=ȝ0).  
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Figure 17 The inhibitory effect of TP on the production of IFN-Ȗ,/-17 and IL-22 by 
naïve T cells at the protein level. (A) Supernatants were harvested for ELISA after 
72h-incubation. (B) Naïve T cells were restimulated with PDBU and ionomycin after 
72h-incubation. Supernatants were harvested for ELISA after 5h-incubation. nsCTRL, 
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naïve T cells treated with only anti-CD3 and anti-CD28; CTRL, naïve T cells treated 
with IL-ȕ,/-6 and IL-23 together with anti-CD3 and anti-CD28. Mean + SD of three 
independent experiments. **P<0.01.* P<0.05. 
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4. Discussion 
Activation of the AhR stimulates T cells to express mRNA and to secrete a range of 
pro-inflammatory cytokines which contributes to specific activation of the immune 
system. It is widely accepted that the majority of the transcriptional activity associated 
with AhR is a consequence of direct agonist binding despite published accounts of 
AhR activity through loss of cell-cell contact without exogenously added ligand (Cho 
et al., 2004;Monk et al., 2001) or via indirect activators such as omeprazole (Backlund 
and Ingelman-Sundberg, 2005). Extended research related to the possible role of 
AhR biology in inflammation and adaptive immunity (De Souza et al., 2009;Esser et 
al., 2009;Patel et al., 2009;Veldhoen et al., 2009), raised the notion that inhibition of 
AhR activity may have therapeutic potential. Thus far, little is known about the 
molecular mechanism of how AhR is involved in immune regulation. It has been 
reported that AhR activated by ligands such as TCDD regulates the generation of 
Tregs and modulates Th1/Th2 balance (Funatake et al., 2005;Negishi, Kato, Ooneda, 
Mimura, Takada, Mochizuki, Yamamoto, Fujii-Kuriyama, and Furusako, 2005). 
However, recent evidence has shown that AhR enhances Th17 differentiation and its 
ligation is essential for induction of IL-22 (Veldhoen et al., 2008). 
6-formylindolo[3,2-b]carbazole (FICZ), a tryptophan-derived photoproduct, is thought 
to be an endogenous agonist with high affinity for the AhR receptor, comparable to 
TCDD (Nguyen and Bradfield, 2008). Ligation of AhR by FICZ upregulates the 
expression of IL-17A, IL-17F and IL-22 in human Th17 cells, as well as induction of 
genes encoding xenobiotic metabolizing cytochrome P450 enzymes such as CYP1A1 
and CYP1B1. AhR antagonists reduce Th17 differentiation in naive CD4+ T cells to 
levels equivalent to those observed for CD4+ T cells from AhR-GH¿FLHQWPLFH (Jeon 
and Esser, 2000). Because Th17 cells are the driving force for autoimmune diseases 
such as inflammatory bowel disease, rheumatoid arthritis, multiple sclerosis and 
psoriasis it seems possible that AhR-activation exacerbates Th17-mediated 
autoimmunity. The molecular mechanisms involved in AhR-modulation of the Th17 
program are currently not well defined. AhR agonists have been shown to repress or 
transactivate NF-kB response genes (Zordoky and El Kadi, 2009). It was recently 
suggested that AhR interacts with STAT1 and STAT5 and that it may regulate Th17 
development by modifying the activation of these two negative regulators of Th17 
generation (Kimura et al., 2008). 
Triptolide has been demonstrated to be effective for the treatment of several 
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autoimmune diseases in both animals and humans (Pan, 1987;Tao et al., 1987). The 
immunosuppressive effects of TP can be partially attributed to its inhibitory effects on 
the production of Th1-type cytokines, but not Th2-type cytokines (Tao et al., 1996;Wu 
et al., 2003b). A recent report showed that triptolide inhibited the differentiation of 
murine CD4+ T cells into Th17 cells and IL-17 mRNA expression in vitro (Wang et al., 
2008b). 
In this study we demonstrated for the first time that TP mediates at least part of its in 
vitro effects via an inhibition of AhR-activation. We were able to show that TP had a 
suppressive effect on Th17 differentiation in human memory T cells and the ability to 
inhibit effects induced by the AhR-agonist FICZ thereby deactivating the AhR 
signaling pathway in both keratinocytes and naive T cells. 
With the methods employed (ELISA and flow cytometry) the inhibitiory effect of TP on 
the biological function of Th1 and Th17 cells was assessed. Consistent with previous 
reports, TP inhibited anti-CD3/anti-CD28 mAbs stimulated IFN-ȖSURGXFWLRQLQKXPDQ
T cells in a dose-dependent manner. In addition, our data confirmed that the presence 
of IL-ȕ ,/-6, IL-23 and TGF-ȕ LQGXFHG an increasing proportion of Th17 cells 
differentiating from human naïve T cells (Stockinger, Veldhoen, and Martin, 
2007;Veldhoen et al., 2008). However, the proportion of Th17 cells generated from 
human naïve T cells was not so apparent compared to the effect in naïve T cells from 
mice. 
In this study it could be shown that exposure of naive T cells to FICZ substantially 
enhanced Th17 polarization and induced IL-22 production. TP inhibited the production 
of IL-17 and IL-22 by more than 95% at a concentration of 0.03µM. The exposure to 
both FICZ and TP at the same concentration of 0.03µM decreased the production of 
IL-17 and IL-22 by about 90% indicating that TP may bind to AhR with a higher affinity 
than FICZ. Moreover, the inhibition of IL-17 and IL-22 production was demonstrated 
after preincubation and subsequent removal of TP from the culture medium before 
FICZ-stimulation. These data suggest that the addition of TP during Th17 polarization 
effectively and directly suppressed differentiation of Th17 cells in vitro. According to 
the results obtained by FACS-analysis, TP exhibited an inhibitory effect on 
FICZ-induced production of IL-17 and IL-22 by memory Th17 cells while having no 
impact on the viability of cells. Unlike CH-223191, the first reported ligand-selective 
antagonist of AhR (Zhao et al., 2010), TP significantly modulated the differentiation of 
Th1 cells (Kim et al., 2006). 
Employing the method of qPCR we showed that TP significantly inhibited IFN-Ȗ,/-17 
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and IL-22 mRNA expression in purified human naive T cells, which is consistent with 
previously reported data obtained in mice (Wang, Jia, and Wu, 2008). In addition, we 
showed for the first time that TP potently down-regulated FICZ-induced CYP1A1 and 
CYP1B1 mRNA expression in both keratinocytes and naive T cells. The 
transcriptional induction of CYP1A1 and CYP1B1 enzyme isoforms is the best 
characterized molecular response to AhR activation (Mimura and Fujii-Kuriyama, 
2003). Several studies have suggested that chronically expressed cytochrome P450 
contributes to TCDD-induced toxicity (Matsumura, 2003;Smith et al., 2001;Uno et al., 
2004). This enzyme catalyzes the epoxidation of certain classes of xenobiotics 
resulting in the generation of highly reactive electrophilic metabolites that may result 
in genotoxicity. This activity also generates NADH-dependent oxygen radicals, which 
may lead to indiscriminate damage to cellular macromolecules and ultimately in 
toxicity (Mandal, 2005;Matsumura, 2003). TP inhibited the FICZ-induced CYP1A1 and 
CYP1B1 mRNA-expression in a concentration-depend manner indicating that TP 
inhibited FICZ-mediated cytochrome P450 induction by transcriptional regulation. 
Therefore, the suppressive effect of TP on IL-17 and IL-22 gene transcription might be 
related to the inhibition of endogenous AhR activity.  
Interestingly, TP revealed no species dependency across the AhR target genes 
examined, which is also in contrast to previously described antagonists (Zhang et al., 
2003). The reason for the variability observed with other reported antagonists is not 
known but may result from the differences in the rate of uptake, metabolism, intrinsic 
variation in binding affinity for the AhR or reflect differences in how AhR activity is 
investigated (Wang and Hankinson, 2002;Zhou and Gasiewicz, 2003).   
TP has been shown to induce cell death in a concentration dependend fashion. 
According to the results of neutral red and MTT assays, TP at the concentration of 
0.05ȝM has no cytostatic effect on keratinocytes. Induction of the early apoptosis 
marker Apo2.7 as measured by FACS analysis occurred at a TP exposure above 
0.03ȝM in naive T cells. This would imply that the suppressive effect of TP on CYPs 
transcription and Th17 differentiation might not be related to cytotoxicity. However, 
this preliminary evidence that TP is non-toxic is limited and restricted to short-term 
outcomes.  
For potential medical application of chemopreventive agents, their safety assessment 
through many toxicity studies have to be performed, and a full understanding of 
pharmacokinetics must be achieved. The study about safety and pharmacokinetics of 
TP deserve further detailed investigation. 
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In conclusion, we have demonstrated for the first time that the small natural occuring 
molecule triptolide is a potent AhR antagonist. Furthermore, TP exhibited a high 
capacity to effectively compete with the established AhR agonist FICZ by inhibiting 
AhR-mediated gene expression and protein secretion. The inhibitory mode of TP 
remains to be fully determined. Importantly, TP treatment of keratinocytes and naïve T 
cells revealed no species dependency with regard to antagonism. Thus, TP 
represents a very potent antagonist of AhR with limited cytotoxicity and its activity as 
an AhR-antagonist may be linked to its anti-inflammatory and immune-suppressive 
effects. Since TP is successfully used as a therapeutic regimen of autoimmune 
disorders in China, our identification of TP as an AhR-antagonist suggests that the 
AhR could be a therapeutic target of interest.  
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5. Summary 
In China extracts of the herb Tripterygium wilfordii Hook F. (TwHF) are successfully 
used to treat psoriasis and other autoimmune and/or inflammatory diseases due to its 
favorable cost-benefit ratio. Triptolide has turned out to be the active substance of 
TwHF-extracts and has been shown to exert potent anti-inflammatory and 
immune-suppressive effects in vitro and in vivo .   
The immunosuppressive action of triptolide has been generally attributed to 
suppression of T-lymphocyte activation. Recently, it was found that triptolide inhibited 
the differentiation of murine CD4+ T cells into Th17 cells and decreased the 
transcription level of interleukin (IL)-17 mRNA and IL-6-induced phosphorylation of 
STAT3, a key signaling molecule involved in the development of Th17 cells.   
The aryl hydrocarbon receptor (AhR) is a ligand-dependent transcription factor best 
known for mediating the toxicity of dioxin. It was shown that in a CD4+ T-cell lineage of 
mice AhR expression is restricted to the Th17 cell subset and its ligation results in the 
production of the Th17 cytokines IL-17 and IL-22. Ligation of AhR by 
6-formylindolo[3,2-b]carbazole (FICZ), a tryptophan-derived photoproduct that is 
thought to be an endogenous agonist with high affinity for the AhR receptor, 
upregulates the expression of IL-17A, IL-17F and IL-22 in human Th17 cells, as well 
as induction of genes encoding for the xenobiotic metabolizing cytochrome P450 
enzymes such as CYP1A1 and CYP1B1.  
From the molecular structure of triptolide the hypothesis was generated that the 
compound could bind to AhR and serve as either agonist or antagonist. For this 
purpose it was investigated whether triptolide could induce cell death and if the 
exposure to triptolide could affect the differentiation of naïve human T cells to Th17 
cells and FICZ induced CYP1A1 and CYP1B1 transcription in both keratinocytes and 
naive T cells. 
The results showed that, comparison of Th17 differentiation in naïve T cells by 
intracellular staining and ELISA after the addition of FICZ together with different 
concentrations of triptolide showed strongly decreased IFN-Ȗ ,/-17A and IL-22 
production in a dose-dependent manner.  
Quantitive PCR demonstrated a significant down-regulation of IFN-Ȗ,/-17A and IL-22 
mRNA expression by triptolide in naive T cells. Additionally, triptolide potently 
down-regulated FICZ-induced CYP1A1 and CYP1B1 mRNA expression in both 
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keratinocytes and naive T cells, which indicates that TP inhibits FICZ-mediated 
cytochrome P450 induction by transcriptional regulation. 
In conclusion, triptolide exhibits a high capacity to effectively compete with AhR 
agonist thus repressing AhR-mediated gene induction and protein expression, and its 
treatment of various cell-types reveals no species dependency with regard to 
antagonism. These data suggest that the activity of triptolide as an AhR-antagonist 
may be linked to its anti-inflammatory and immune-suppressive effects. Since 
triptolide is successfully used as a therapeutic of autoimmune disorders in China our 
identification of triptolide as an AhR-antagonist suggests that the AhR could be a 
therapeutic target of interest.  
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